Cargando…
B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
Type 1 diabetes (T1D) is a chronic autoimmune disease and characterized by absolute insulin deficiency. β-cell replacement by islet cell transplantation has been established as a feasible treatment option for T1D. The two main obstacles after islet transplantation are alloreactive T-cell-mediated gr...
Autores principales: | Wang, Xiaojie, Hao, Jianqiang, Metzger, Daniel L., Ao, Ziliang, Meloche, Mark, Verchere, C. Bruce, Chen, Lieping, Ou, Dawei, Mui, Alice, Warnock, Garth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196026/ https://www.ncbi.nlm.nih.gov/pubmed/22028949 http://dx.doi.org/10.1155/2011/418902 |
Ejemplares similares
-
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
por: Wang, Xiaojie, et al.
Publicado: (2012) -
Improving Islet Engraftment by Gene Therapy
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Generation of Transplantable Beta Cells for Patient-Specific Cell Therapy
por: Wang, Xiaojie, et al.
Publicado: (2012) -
Advances and Challenges in Islet Transplantation: Islet Procurement Rates and Lessons Learned from Suboptimal Islet Transplantation
por: Plesner, Annette, et al.
Publicado: (2011)